Disease-Modifying Therapy for Multiple Sclerosis & Neuroimmunological Disorders

Disease-modifying therapies are used in selected neuroimmunological conditions to reduce disease activity and the risk of future neurological disability.

In multiple sclerosis, treatment selection depends on disease pattern, activity, previous treatment, risk factors and individual circumstances.

The aim is to control disease activity while balancing treatment effectiveness, safety and the patient's preferences.

Regular clinical follow-up and appropriate investigations are important to monitor treatment response and safety.